A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants
Clinical trial NCT03123848 · COMPLETED
Trial details
- NCT number
- NCT03123848
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-14
- Primary completion
- 2017-05-19
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.